FDA Approved: DASATINIB — Original Application (Prasco Laboratories)

View source ↗

Summary

FDA approved dasatinib under an original application submitted by Prasco Laboratories. The approval covers treatment of Philadelphia chromosome-positive leukemi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia
• Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Drugs mentioned

• DASATINIB (Dasatinib)

Snippet

ORIG AP for DASATINIB (DASATINIB)